Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis lipid levels and mortality after obesity-related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort
    Journal Article

    Hovsepyan, G.; Barac, A.; Brasky, T. M.; Shadyab, A. H.; Lehman, A.; McLaughlin, E. M.; Saquib, N.; Iyengar, N. M.; Wild, R. A.; Caan, B. J.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: Subgroup analysis of a randomized clinical trial
    Journal Article

    Bao, T.; Zhi, W. I.; Baser, R. E.; Li, Q. S.; Weitzman, M.; Gillespie, E. F.; Robson, M.; Mao, J. J.
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment
    Meeting Abstract

    Saint, K.; Han, K.; Piulson, L.; Seluzicki, C.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer
    Meeting Abstract

    Lopez-Nieves, I.; Chiang, C.; Han, K.; Piulson, L.; Seluzicki, C.; Weitzman, M.; Zhang, Y. L.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Abaya, C. D.; Martinez, C.; Basho, R. K.; McAndrew, P.; Larkin, B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • evERA Breast Cancer (BC): Phase III study of giredestrant + everolimus vs exemestane + everolimus in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced or metastatic BC (ER+, HER2– LA/mBC)
    Meeting Abstract

    Mayer, E. L.; Tolaney, S. M.; Brufsky, A.; Gradishar, W. J.; Jhaveri, K. L.; Martin, M.; Moscetti, L.; Schneeweiss, A.; Vidal, G. A.; Cortazar, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Harnessing olaparib, palbociclib, and endocrine therapy: A phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA mutation-associated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HOPE)
    Meeting Abstract

    Torres, A.; Aaron, M.; White, L.; D'Andrea, K.; Narayan, V.; Knollman, H. M.; Bradbury, A. R.; Tung, N. M.; Robson, M. E.; Nathanson, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early integration of exercise into breast cancer care: The MSK healthy living program
    Meeting Abstract

    Rowed, K.; Shen, S.; Smith, A.; Kelly, B.; Magnoli, R.; Corcoran, S.; Emerzian, M.; Ackerman, K.; Cruz, C.; Salehi, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world clinical outcomes in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)
    Meeting Abstract

    Tolaney, S. M.; Punie, K.; Kurian, A. W.; Ntalla, I.; Verret, W.; Sadetsky, N.; Sjekloca, N.; Stokes, M.; Jhaveri, K. L.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save